Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer

This publication has 17 references indexed in Scilit:

• The IGF-I Receptor in Cancer Research
  Experimental Cell Research, 1999
• TSH-secreting pituitary macroadenoma: Rapid tumor shrinkage and recovery from hyperthyroidism with octreotide
  Journal of Endocrinological Investigation, 1999
• Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery
  Cell, 1997
• Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells
  Proceedings of the National Academy of Sciences, 1997
• Mutant IGF-I Receptors as Dominant Negatives for Growth and Transformation
  Biochemical and Biophysical Research Communications, 1995
• Oncogenes and the strategy of growth factors
  Cell, 1994
• Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.
  Proceedings of the National Academy of Sciences, 1994
• Chapter 8 Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells
  Published by Elsevier ,1994
• Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.
  Proceedings of the National Academy of Sciences, 1992
• Manipulation of Adenovirus Vectors
  Published by Springer Nature ,1990